E. O. Adediran, “Pefloxacin and its derivative, novel inhibitors of the SARS-CoV-2 Main protease (3CLpro) and their pharmacokinetics prediction: An in silico analysis”, Arch Pharm Pharma Sci, vol. 6, no. 1, pp. 013–018, Jun. 2022.